ArticleAnnals of medicine and surgery (2012)2024
Unilateral adrenal metastases as an unusual primary presentation of hepatocellular carcinoma: a case report and literature review.
Article in Annals of medicine and surgery (2012), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical outcomes and prognostic factors after adrenalectomy for adrenal metastasis from hepatocellular carcinoma.Annals of hepato-biliary-pancreatic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Adrenal metastases can rarely present as a solitary clinical manifestation among cases with underlying hepatocellular carcinoma (HCC). Case presentation: The authors present the case of a 53-year-old male with chronic liver disease due to chronic hepatitis C who presented with left flank pain. Imaging revealed a left-sided suprarenal mass. Following multidisciplinary assessment, the patient underwent left-sided nephrectomy and adrenalectomy, whereas histopathological correlation revealed microscopic foci of metastatic HCC in the resected gland. Postoperative abdominal imaging then revealed multifocal dysplastic lesions scattered through both the hepatic lobes. Subsequently, systemic treatment was initiated with sorafenib. Clinical discussion: These types of adrenal metastasis from the liver are extremely uncommon and need detailed evaluation of the liver and other potential metastatic sites. The choice of treatment will be indicated according to the type and site of the tumor. Conclusion: This case highlights the significance of thorough evaluation and individualized management in HCC-associated adrenal metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.